Anticoagulant use in renal replacement therapy in the Mid Trent Critical Care Network: A survey of practice

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Anticoagulant drug use is one of the methods employed to prolong filter life during renal replacement therapy in the critically ill patient. In the Mid Trent Critical Care network, a variety of anticoagulant regimens are used with varying efficacy. This is a retrospective survey of anticoagulant regimens, comparing mechanical filter life, blood product use and documented complications in the five largest units using renal replacement therapy in the region, and to evaluate how effective our regimens were compared to standards defined in the medical literature. © The Intensive Care Society 2010.

Cite

CITATION STYLE

APA

Sharman, A., Gardiner, D., & Girling, K. (2010). Anticoagulant use in renal replacement therapy in the Mid Trent Critical Care Network: A survey of practice. Journal of the Intensive Care Society, 11(2), 138–143. https://doi.org/10.1177/175114371001100216

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free